Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2009 Mar;15(2):83-97.
doi: 10.1016/j.cardfail.2009.01.006.

Genetic Evaluation of Cardiomyopathy--A Heart Failure Society of America Practice Guideline

Affiliations
Practice Guideline

Genetic Evaluation of Cardiomyopathy--A Heart Failure Society of America Practice Guideline

Ray E Hershberger et al. J Card Fail. .

Abstract

Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

Comment in

Similar articles

See all similar articles

Cited by 150 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback